ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,650.00
14.00 (0.86%)
Last Updated: 12:00:12
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  14.00 0.86% 1,650.00 1,649.50 1,650.50 1,656.00 1,635.00 1,642.00 1,414,338 12:00:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.80 68.01B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,636p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.01 billion. Gsk has a price to earnings ratio (PE ratio) of 13.80.

Gsk Share Discussion Threads

Showing 32751 to 32774 of 33100 messages
Chat Pages: Latest  1312  1311  1310  1309  1308  1307  1306  1305  1304  1303  1302  1301  Older
DateSubjectAuthorDiscuss
22/11/2023
08:02
GSK3437949 Malaria next generation (fractional dose)?
tradermichael
21/11/2023
16:07
Word on the street have a game changing malaria vacine in final trails.
giltedge1
17/11/2023
10:28
Money moving to APH
blackhorse23
16/11/2023
11:43
From now ?
panache1
16/11/2023
09:09
Is this as low as it's going today ex div ? That would be good
panache1
15/11/2023
19:11
So I've held since 2001 and I can honestly only think of the following when sentiment was good:- 2001 - Advair launch - 2006 - some excitement about some new respiratory drugs - 2012/13 - excitement about the 'big 6' in the pipeline (mixture of respiratory, HIV and CVS drugs)- 2017 - new CEO bounce? :)- 2019/20 - Run of good results and pipeline looking better - 2022 - Riding high until demerger and double whammy of lower divi and Zantac litigation Obviously this is from memory and not perfect but I would say in that 23 year timeline I've been following it that sentiment has been poor at least two thirds of that time..
rikky72
15/11/2023
12:02
For most of its existence, sentiment towards GSK has been very poor. Doesn’t look like that’s changing anytime soon. Definitely frustrating though.

I've held since dinosaurs roamed and your comment is accurate though I wouldnt say the poor sentiment has been "for most of its existence". Hard to see now but long ago there was a time whn the share was quite highly regarded as shown by a yield of only about 2%.

However the poor sentiment of more recent years is not baseless. For some time the company has delivered poor financial results, not helped by increasingly monstrous debt. So even an upturn in its fortunes will take a while to impress cynical institutional investors who I think have long held, and rightly, a less than optimistic opinion of the company.

The best thing imo they have done recently is the HLN demerger and I continue to hold my allocation. I'm primarily an income investor but if I look at the capital performance over the decades, it's only because HLN is showing a profit that my combined holding is showing a tiny profit over the original cost of old GSK after all these years, as new GSK is showing a loss over the demerger adjusted price.

As for income, which is my reason for holding equities at all, that has also been trashed following the demerger.

I'm guessing that sooner or later this crock GSK will probably be turned round, something that management has singularly failed to do for many years. Not sure I'll live that long though...

anhar
15/11/2023
09:37
GSK share price going against the rise in the Ftse,getting ready for the double drop tomorrow due to X-div
abdullla
14/11/2023
18:41
You can't argue with facts GSK shareprice below what it was 30 years ever since they merged with Smith Kline Beecham.
montyhedge
14/11/2023
16:21
For most of its existence, sentiment towards GSK has been very poor. Doesn't look like that's changing anytime soon. Definitely frustrating though.
rikky72
14/11/2023
16:04
Never seen a share react so badly to good news
spoole5
14/11/2023
14:42
Could end up in a disaster
abdullla
13/11/2023
14:36
Diving into red soon
abdullla
13/11/2023
12:19
GSK said it has received a positive opinion recommending the approval of its blood-cancer treatment momelotinib from the European Medicines Agency.

The British pharmaceutical giant said the decision on marketing authorization in the EU is expected by early 2024.

The positive opinion was adopted by the Committee for Medicinal Products for Human Use--or CHMP--of the European Medicines Agency, and is one of the final steps prior to marketing authorization decision by the European Commission.

If approved, momelotinib would be the only medicine in the EU specifically for both newly diagnosed and previously treated patients with myelofibrosis--a rare type of blood cancer--and moderate to severe anaemia, that addresses enlarged spleen and symptoms.

tradermichael
10/11/2023
15:50
I agree R72. The problem is that this is exactly where it was a decade + ago... It's like a dying dodo which needs to be put out of its misery!!
theoriginalwonderstuff
10/11/2023
15:35
It's not going to happen. Their near term pipeline is not compelling enough, execution of this scale is always messy and the final nail is that any would be acquirer would face resistance from the UK government.But hopefully things will perk up for it within a year or so organically. There is certainly potential there.
rikky72
10/11/2023
11:03
Are there any circumstances in which someone might launch a takeover bid for GSK?? It's been languishing for years. Is it too much of a behemoth to be taken over? Too unruly? Too big?? Or just too much of a basket case?!
theoriginalwonderstuff
03/11/2023
14:53
These gyrations happen from time to time. Kicking when down is good sport for some. Good luck to them.
patientcapital
03/11/2023
13:10
Take a good, long look at GSK's new product pipeline. Many late stage oncology drugs there, specifically employing monoclonal antibody science - these and many others (vaccines included) are first or best in class.
tradermichael
02/11/2023
23:28
Patient Capital, the real growth story here is baloney and Monty points to share price performance over 20+ years as proof pudding (it's not the markets fault). Vaccines don't, unfairly imo, cut the same ice as blockbuster statins, weight suppressants or oncology drugs.
Until she delivers GROWTH investors want dividends and too many are giving 8% (lgen, bdev, hbr etc and have been decimated but are still excellent companies) to make GSK's (pipedream) 3.95% less than tempting.
The day's of pharma being a ;special' case are gone-investors want return for risk and Emma is not quite getting it. She needs to give 6% (74P) to maintain current share price or see a drift to low £12s as investors opt for safe treasuries yielding 5%+ which will be available for the next year. Otherwise she needs to pack her bags asap. imo

cumnor
02/11/2023
15:23
Yes you only need 3 shares to have a monthly income stream, Jan to Dec.GSK, Unilever and my favourite Bats with a high yield nearly 9%, of course you could have BP as well.
montyhedge
02/11/2023
15:23
And the chances of a fall on 16 November (x div)??
tradermichael
02/11/2023
14:58
Ftse having been up today will lose its steam tomorrow which means GSK will most likely fall again .
abdullla
02/11/2023
14:43
I'm not putting any more money in here. Best option it to trade the range i suppose.I will wait until it is 1500 and sell some
supermarky
Chat Pages: Latest  1312  1311  1310  1309  1308  1307  1306  1305  1304  1303  1302  1301  Older

Your Recent History

Delayed Upgrade Clock